The outcomes confirm conclusions drawn by Bagli et al. [one], who done a examine that incorporated ten patients diagnosed with CRAO who received HBOT. In addition to receiving 20 periods of HBOT, oral acetazolamide and topical beta-blockers ended up administered to your patients at the earliest possible time.Youn et al. [fifty four] highlighted The